Helena Gylling mainly investigates Cholesterol, Internal medicine, Endocrinology, Sterol and Lathosterol. Her research in Plant stanol ester, Cholestanol, Lipoprotein, Stanol ester and Campesterol are components of Cholesterol. She has researched Plant stanol ester in several fields, including Food science, Risk factor and Campestanol.
Her study in Reverse cholesterol transport, Very low-density lipoprotein, Apolipoprotein B, Diabetes mellitus and Diet therapy are all subfields of Endocrinology. Her Sterol research focuses on Metabolism and how it connects with Homeostasis and Biosynthesis. She works mostly in the field of Lathosterol, limiting it down to topics relating to Desmosterol and, in certain cases, Insulin resistance.
Helena Gylling focuses on Internal medicine, Endocrinology, Cholesterol, Sterol and Lathosterol. Her Internal medicine research is multidisciplinary, incorporating elements of Diabetes mellitus and Squalene. Her Endocrinology study is mostly concerned with Lipoprotein, Metabolism, Apolipoprotein B, Blood lipids and Reverse cholesterol transport.
Campesterol, Cholestanol, Desmosterol, Very low-density lipoprotein and Plant stanol ester are the subjects of her Cholesterol studies. Her studies in Plant stanol ester integrate themes in fields like Statin, Phytosterol, Food science and Stanol ester. Her Lathosterol research integrates issues from Simvastatin and High cholesterol.
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Cholesterol, Plant stanol ester and Blood lipids. Lathosterol, Adipose tissue, Insulin, Weight loss and Impaired glucose tolerance are subfields of Internal medicine in which her conducts study. Her research related to Campesterol, Type 2 diabetes, Lipid metabolism, Metabolic syndrome and Insulin resistance might be considered part of Endocrinology.
Her research brings together the fields of Intestinal absorption and Cholesterol. Her Plant stanol ester research incorporates elements of Statin, Ezetimibe, Food science and Cholesterol absorption. Her biological study spans a wide range of topics, including Fat-Soluble Vitamin and Blood serum.
Her primary scientific interests are in Internal medicine, Endocrinology, Cholesterol, Type 2 diabetes and Lipid metabolism. Her Internal medicine study frequently links to related topics such as Diabetes mellitus. Her Insulin resistance, Campesterol, Blood lipids, Insulin and Metabolic syndrome study are her primary interests in Endocrinology.
Her Campesterol research is multidisciplinary, relying on both Histology and Apolipoprotein B. Her study in Cholesterol focuses on Desmosterol, Lathosterol and Plant stanol ester. Her work carried out in the field of Lipid metabolism brings together such families of science as Roux-en-Y anastomosis, Gastric bypass, Lipid oxidation and Bile acid.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population
Tatu A. Miettinen;Pekka Puska;Helena Gylling;Hannu Vanhanen.
The New England Journal of Medicine (1995)
Lifestyle intervention with weight reduction: first-line treatment in mild obstructive sleep apnea.
Henri P. I. Tuomilehto;Juha M. Seppä;Markku M. Partinen;Markku Peltonen.
American Journal of Respiratory and Critical Care Medicine (2009)
Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease
Helena Gylling;Jogchum Plat;Stephen Turley;Henry N. Ginsberg.
Comparison of the effects of plant sterol ester and plant stanol ester-enriched margarines in lowering serum cholesterol concentrations in hypercholesterolaemic subjects on a low-fat diet.
M. A. Hallikainen;E. S. Sarkkinen;H. Gylling;A. T. Erkkilä.
European Journal of Clinical Nutrition (2000)
Baseline serum cholestanol as predictor of recurrent coronary events in subgroup of Scandinavian simvastatin survival study
Tatu A Miettinen;Helena Gylling;Timo Strandberg;Seppo Sarna.
Reduction of Serum Cholesterol in Postmenopausal Women With Previous Myocardial Infarction and Cholesterol Malabsorption Induced by Dietary Sitostanol Ester Margarine Women and Dietary Sitostanol
Helena Gylling;Rajaratnam Radhakrishnan;Tatu A. Miettinen.
Serum cholesterol and cholesterol and lipoprotein metabolism in hypercholesterolaemic NIDDM patients before and during sitostanol ester-margarine treatment.
H. Gylling;T. A. Miettinen.
Noncholesterol Sterols and Cholesterol Lowering by Long-Term Simvastatin Treatment in Coronary Patients Relation to Basal Serum Cholestanol
T. A. Miettinen;T. E. Strandberg;H. Gylling.
Arteriosclerosis, Thrombosis, and Vascular Biology (2000)
Sitostanol ester margarine in dietary treatment of children with familial hypercholesterolemia
H Gylling;M.A. Siimes;T.A. Miettinen.
Journal of Lipid Research (1995)
Cholesterol reduction by different plant stanol mixtures and with variable fat intake
Helena Gylling;Tatu A. Miettinen.
Metabolism-clinical and Experimental (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: